Cargando…
Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Autores principales: | Amalia, Maya Rosana, Herminingsih, Susi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785078/ https://www.ncbi.nlm.nih.gov/pubmed/35106077 http://dx.doi.org/10.15420/ecr.2021.16.PO5 |
Ejemplares similares
-
Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome
por: Uzokov, J, et al.
Publicado: (2020) -
Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: Dastan, F
Publicado: (2020) -
Best Poster Award – Third Prize: The Perilousness of Antidepressant Drugs in a Real-world Cohort of Patients with Acute Coronary Syndrome
por: Denegri, A, et al.
Publicado: (2020) -
A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
por: Matsuda, M, et al.
Publicado: (2020) -
Hypotensive Action of Melatonin in Patients with Arterial Hypertension
por: Ahsanova, E, et al.
Publicado: (2020)